Locust Walk examined the evolving landscape of cross-border transactions involving Chinese biotech and what it truly takes to succeed as a global dealmaker in today’s market.
Podcast: Play in new window | Download (Duration: 7:35 — 6.9MB)
Subscribe: Apple Podcasts | Spotify | RSS
During the Asia-focused Episode 35 of Biotalk, Geoff Meyerson, CEO of Locust Walk, reviews key 2026 Q1 Report: Global Trends in Biopharma Transactions trends across China,
Podcast: Play in new window | Download (Duration: 5:12 — 9.5MB)
Subscribe: Apple Podcasts | Spotify | RSS
During Episode 34 of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2026 Q1 Report: Global Trends in Biopharma Transactions, covering capital markets, strategic deals, and
Each quarter, Locust Walk’s deal team compiles key statistics and trends on strategic transactions and financings. Our 2026 Q1 Report applies the latest data to analyze the current landscape in life sciences deals.
Podcast: Play in new window | Download (Duration: 6:08 — 14.0MB)
Subscribe: Apple Podcasts | Spotify | RSS
During the Asia-focused Episode 33 of Biotalk, Geoff Meyerson, CEO of Locust Walk, reviews key 2025 Year-In-Review trends across China, Japan, and
Podcast: Play in new window | Download (Duration: 11:24 — 26.1MB)
Subscribe: Apple Podcasts | Spotify | RSS
During Episode 32 of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2025 Year-In-Review Report: Global Trends in Biopharma
Locust Walk conducted a multi‑year analysis of JPM‑week deal activity to evaluate whether early‑January partnering and M&A activity can reliably benchmark and anticipate full‑year dealmaking momentum across global biopharma.
Each quarter, Locust Walk’s deal team compiles key statistics and trends on strategic transactions and financings. Our 2025 Year-In-Review Report applies the latest data to analyze the current landscape in life sciences deals.
Podcast: Play in new window | Download (Duration: 4:44 — 10.8MB)
Subscribe: Apple Podcasts | Spotify | RSS
During Episode 31 of Biotalk, Geoff Meyerson, CEO of Locust Walk, explores Asia-Pacific biotech momentum across China, Japan, and Korea, as featured
Podcast: Play in new window | Download (Duration: 13:18 — 30.4MB)
Subscribe: Apple Podcasts | Spotify | RSS
During Episode 30 of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2025 Q3 Report: Global Trends in Biopharma